Network-Based Methods for Prediction of Drug-Target Interactions
暂无分享,去创建一个
Zengrui Wu | Guixia Liu | Weihua Li | Yun Tang | Weihua Li | Zengrui Wu | Guixia Liu | Yun Tang
[1] Chuipu Cai,et al. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy , 2017, J. Chem. Inf. Model..
[2] Xiaowei Yang,et al. Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine , 2014, PLoS Comput. Biol..
[3] S. Brunak,et al. A scored human protein–protein interaction network to catalyze genomic interpretation , 2017, Nature Methods.
[4] C. Hutter,et al. Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants , 2015 .
[5] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[6] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[7] Shuigeng Zhou,et al. Boosting compound-protein interaction prediction by deep learning , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[8] Zhihai Liu,et al. Forging the Basis for Developing Protein-Ligand Interaction Scoring Functions. , 2017, Accounts of chemical research.
[9] Peer Bork,et al. The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..
[10] Weihua Li,et al. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. , 2010, Journal of medicinal chemistry.
[11] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform And The First 1,000,000 Profiles , 2017 .
[12] Hsinchun Chen,et al. A Comparison of Collaborative-Filtering Recommendation Algorithms for E-commerce , 2007, IEEE Intelligent Systems.
[13] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[14] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[15] Xing Chen,et al. Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.
[16] Thomas C. Wiegers,et al. The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..
[17] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[18] Cheng Luo,et al. Computational methods for drug design and discovery: focus on China , 2013, Trends in Pharmacological Sciences.
[19] Tao Zhou,et al. Predicting missing links and identifying spurious links via likelihood analysis , 2016, Scientific Reports.
[20] Yanli Wang,et al. PubChem BioAssay: 2017 update , 2016, Nucleic Acids Res..
[21] David S. Roos,et al. TDR Targets: a chemogenomics resource for neglected diseases , 2011, Nucleic Acids Res..
[22] Jie Li,et al. In silico prediction of chemical mechanism of action via an improved network‐based inference method , 2016, British journal of pharmacology.
[23] Feixiong Cheng,et al. Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders , 2017, Front. Pharmacol..
[24] Jie Shen,et al. admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..
[25] Salvatore Alaimo,et al. Drug–target interaction prediction through domain-tuned network-based inference , 2013, Bioinform..
[26] Jie Shen,et al. Adverse Drug Events: Database Construction and in Silico Prediction , 2013, J. Chem. Inf. Model..
[27] Barry Honig,et al. Structure-based prediction of ligand–protein interactions on a genome-wide scale , 2017, Proceedings of the National Academy of Sciences.
[28] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[29] David S. Goodsell,et al. The RCSB protein data bank: integrative view of protein, gene and 3D structural information , 2016, Nucleic Acids Res..
[30] Xiufeng Pang,et al. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein‐coupled receptor ligands via network‐based approaches , 2017, Pharmacological research.
[31] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[32] Panos Kalnis,et al. DASPfind: new efficient method to predict drug–target interactions , 2016, Journal of Cheminformatics.
[33] E. Schadt. The changing privacy landscape in the era of big data , 2012, Molecular systems biology.
[34] D. E. Clark,et al. Outstanding challenges in protein–ligand docking and structure‐based virtual screening , 2011 .
[35] M. Newman,et al. Hierarchical structure and the prediction of missing links in networks , 2008, Nature.
[36] Nicholas C. Ide,et al. The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.
[37] Wei Liu,et al. Successful Strategies to Determine High-Resolution Structures of GPCRs. , 2016, Trends in pharmacological sciences.
[38] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[39] P. Willett,et al. Promoting Access to White Rose Research Papers Similarity-based Virtual Screening Using 2d Fingerprints , 2022 .
[40] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[41] Jie Li,et al. PDB-wide collection of binding data: current status of the PDBbind database , 2015, Bioinform..
[42] Yi-Cheng Zhang,et al. Bipartite network projection and personal recommendation. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.
[43] Hua Yu,et al. A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.
[44] Tingting Fu,et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics , 2017, Nucleic Acids Res..
[45] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[46] Lin He,et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..
[47] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[48] Jie Li,et al. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug–target interactions and drug repositioning , 2016, Briefings Bioinform..
[49] Guixia Liu,et al. Performance Evaluation of 2D Fingerprint and 3D Shape Similarity Methods in Virtual Screening , 2012, J. Chem. Inf. Model..
[50] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[51] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[52] PeskaLadislav,et al. Drug-target interaction prediction , 2017 .
[53] Yuhao Wang,et al. Predicting drug-target interactions using restricted Boltzmann machines , 2013, Bioinform..
[54] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..
[55] B. Roth,et al. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .
[56] Weihua Li,et al. Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays. , 2012, Journal of medicinal chemistry.
[57] Russ B. Altman,et al. PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..
[58] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[59] Simone Daminelli,et al. Common neighbours and the local-community-paradigm for topological link prediction in bipartite networks , 2015, ArXiv.
[60] Jie Shen,et al. Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs). , 2013, Molecular bioSystems.
[61] Hao Ding,et al. Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..
[62] Ruben Abagyan,et al. The GPCR Network: a large-scale collaboration to determine human GPCR structure and function , 2012, Nature Reviews Drug Discovery.
[63] Lei Chen,et al. Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening , 2014, Acta Pharmacologica Sinica.
[64] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[65] Man Mohan Mehndiratta,et al. Drug repositioning , 2016, International Journal of Epilepsy.
[66] Xiaofeng Liu,et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..
[67] Sophie Ahrens,et al. Recommender Systems , 2012 .
[68] Alasdair J. G. Gray,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY , 2017, Nucleic Acids Res..
[69] Yadi Zhou,et al. Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method , 2012, PloS one.
[70] Philip C Biggin,et al. Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations , 2016, Journal of the American Chemical Society.
[71] Didier Rognan,et al. Structure‐Based Approaches to Target Fishing and Ligand Profiling , 2010, Molecular informatics.
[72] Konrad F. Koehler,et al. Development of subtype-selective oestrogen receptor-based therapeutics , 2011, Nature Reviews Drug Discovery.
[73] Timothy Ravasi,et al. From link-prediction in brain connectomes and protein interactomes to the local-community-paradigm in complex networks , 2013, Scientific Reports.
[74] Richard D. Smith,et al. Recent improvements to Binding MOAD: a resource for protein–ligand binding affinities and structures , 2014, Nucleic Acids Res..
[75] Dik-Lung Ma,et al. Drug repositioning by structure-based virtual screening. , 2013, Chemical Society reviews.
[76] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[77] Tudor I. Oprea,et al. DrugCentral: online drug compendium , 2016, Nucleic Acids Res..
[78] Ilenia Giangreco,et al. Protein-Ligand Informatics Force Field (PLIff): Toward a Fully Knowledge Driven "Force Field" for Biomolecular Interactions. , 2016, Journal of medicinal chemistry.
[79] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[80] Yadi Zhou,et al. Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods. , 2012, Molecular bioSystems.
[81] Yi Pan,et al. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..
[82] Jie Li,et al. Prediction of Polypharmacological Profiles of Drugs by the Integration of Chemical, Side Effect, and Therapeutic Space , 2013, J. Chem. Inf. Model..
[83] Ming Wen,et al. Deep-Learning-Based Drug-Target Interaction Prediction. , 2017, Journal of proteome research.
[84] J. Medina-Franco,et al. Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.
[85] Roger Guimerà,et al. Missing and spurious interactions and the reconstruction of complex networks , 2009, Proceedings of the National Academy of Sciences.
[86] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[87] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[88] Maria F. Sassano,et al. Automated design of ligands to polypharmacological profiles , 2012, Nature.
[89] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[90] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[91] C. Chong,et al. New uses for old drugs , 2007, Nature.
[92] J. Bajorath,et al. Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.
[93] Aarno Vuola,et al. Predicting Drug-Target Interactions , 2016 .
[94] Feixiong Cheng,et al. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science. , 2015, Biomarkers in medicine.
[95] Philip E. Bourne,et al. SuperTarget goes quantitative: update on drug–target interactions , 2011, Nucleic Acids Res..
[96] Kai Huang,et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..
[97] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[98] Avi Ma'ayan,et al. Lean Big Data integration in systems biology and systems pharmacology. , 2014, Trends in pharmacological sciences.
[99] Feixiong Cheng,et al. In silico ADMET prediction: recent advances, current challenges and future trends. , 2013, Current topics in medicinal chemistry.
[100] Mathieu Lemire,et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. , 2015, JAMA.
[101] Polina Mamoshina,et al. Design of efficient computational workflows for in silico drug repurposing. , 2017, Drug discovery today.
[102] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[103] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[104] Weiliang Zhu,et al. New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.
[105] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[106] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[107] Antonio Lavecchia,et al. In silico methods to address polypharmacology: current status, applications and future perspectives. , 2016, Drug discovery today.
[108] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[109] Chirag J Patel,et al. A standard database for drug repositioning , 2017, Scientific Data.
[110] Linyuan Lu,et al. Link prediction based on local random walk , 2010, 1001.2467.
[111] Michael Schroeder,et al. Pioneering topological methods for network-based drug–target prediction by exploiting a brain-network self-organization theory , 2017, Briefings Bioinform..
[112] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[113] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results , 2014, J. Chem. Inf. Model..
[114] M. Khoury,et al. A navigator for human genome epidemiology , 2008, Nature Genetics.
[115] François Schiettecatte,et al. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..
[116] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[117] Li Gong,et al. The Hidden Flow Structure and Metric Space of Network Embedding Algorithms Based on Random Walks , 2017, Scientific Reports.
[118] Damian Szklarczyk,et al. STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..
[119] Hsinchun Chen,et al. A comparison of collaborative-filtering algorithms for ecommerce , 2007 .
[120] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[121] Linyuan Lu,et al. Link Prediction in Complex Networks: A Survey , 2010, ArXiv.
[122] Yi-Cheng Zhang,et al. Solving the apparent diversity-accuracy dilemma of recommender systems , 2008, Proceedings of the National Academy of Sciences.
[123] Yong-Yeol Ahn,et al. Optimizing drug–target interaction prediction based on random walk on heterogeneous networks , 2015, Journal of Cheminformatics.